CD274 and non-small cell lung carcinoma: The UT Southwestern group explored chemotherapy-free treatment with radiotherapy and durvalumab in patients with LA-NSCLC who were unselected with respect to PD-L1 expression and generally would have been fit for chemoradiotherapy [27].